Gene · 6504
Papers3,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD244 expression represents functional decline of murine hematopoietic stem cells after in vitro culture. | iScience | 2022 | 35005548 | PubTator, text mining | PubMed |
| Naive and memory CD4+ T cell subsets can contribute to the generation of human Tfh cells. | iScience | 2022 | 34984326 | PubTator, text mining | PubMed |
| Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting. | Life Sci Alliance | 2022 | 34952892 | PubTator, text mining | PubMed |
| Modeling human yolk sac hematopoiesis with pluripotent stem cells. | J Exp Med | 2022 | 34928315 | PubTator, text mining | PubMed |
| Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis. | Rheumatol Ther | 2022 | 34878629 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| SETD5 modulates homeostasis of hematopoietic stem cells by mediating RNA Polymerase II pausing in cooperation with HCF-1. | Leukemia | 2022 | 34853439 | PubTator, text mining | PubMed |
| Novel associations between inflammation-related proteins and adiposity: A targeted proteomics approach across four population-based studies. | Transl Res | 2022 | 34780968 | PubTator, text mining | PubMed |
| Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. | Cancer Sci | 2022 | 34773335 | PubTator, text mining | PubMed |
| Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity. | Blood | 2022 | 34767029 | PubTator, text mining | PubMed |
| Effects of TNF-α deletion on iNKT cell development, activation, and maturation in the steady-state and chronic alcohol-consuming mice. | J Leukoc Biol | 2022 | 34766371 | PubTator, text mining | PubMed |
| Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions. | J Allergy Clin Immunol Pract | 2022 | 34757064 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure. | Haematologica | 2022 | 34706493 | PubTator, text mining | PubMed |
| Apolipoprotein A1 deficiency in mice primes bone marrow stem cells for T cell lymphopoiesis. | J Cell Sci | 2022 | 34698355 | PubTator, text mining | PubMed |
| A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL. | Blood Adv | 2022 | 34638128 | PubTator, text mining | PubMed |
| JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β. | Blood Adv | 2022 | 34555844 | PubTator, text mining | PubMed |
| Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha-Methylacyl-Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen-Activated Protein Kinase. | Hepatol Commun | 2022 | 34505419 | PubTator, text mining | PubMed |
| Asymptomatic incidental neuroblastoma in a patient with SH2D1A deficiency. | Pediatr Blood Cancer | 2022 | 34455705 | PubTator, text mining | PubMed |
| Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy. | Leuk Lymphoma | 2022 | 34407733 | PubTator, text mining | PubMed |
| The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris. | J Am Acad Dermatol | 2022 | 34339761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6504/papers?page=40